Role of histone deacetylase expression in intrahepatic cholangiocarcinoma

Surgery

Volumn 151, Issue 3, 2012, Pages 412-419

  Morine, Yuji ^a   Shimada, Mitsuo ^a   Iwahashi, Shuichi ^a   Utsunomiya, Tohru ^a   Imura, Satoru ^a   Ikemoto, Tetsuya ^a   Mori, Hiroki ^a   Hanaoka, Jun ^a   Miyake, Hidenori ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER STAGING; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER LOBECTOMY; LIVER RESECTION; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CHOLANGIOCARCINOMA; DISEASE-FREE SURVIVAL; EPIGENESIS, GENETIC; FEMALE; HISTONE DEACETYLASE 1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS;

EID: 84857055224     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2011.07.038     Document Type: Article

References (33)

1. The Liver Study Group of Japan The 16th report, surveillance of primary liver cancer patients in National Registry 2005 LCSGJ Kyoto
2. F.A. Casavilla, J.W. Marsh, S. Iwatsuki, S. Todo, R.G. Lee, and J.R. Madariaga Hepatic resection and transplantation for peripheral cholangiocarcinoma J Am Coll Surg 185 1997 429 436 (Pubitemid 27475441)
3. W.K. Washburn, W.D. Lewis, and R.L. Jenkins Aggressive surgical resection for cholangiocarcinoma Arch Surg 130 1995 270 276
4. S. Roayaie, J.V. Guarrera, M.Q. Ye, S.N. Thung, S. Emre, and T.M. Fishbein Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes J Am Coll Surg 187 1998 365 372 (Pubitemid 28467611)
5. S. Isaji, Y. Kawarada, H. Taoka, M. Tabata, H. Suzuki, and H. Yokoi Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan J Hepatobiliary Pancreat Surg 6 1999 108 116
6. J. Kacznski, G. Hanson, and S. Wallerstedt Incidence, etiologic aspects and clinicopathological features in intrahepatic cholangiocaltinoma-a study of 51 cases from a low endemicity area Acta Oncol 37 1988 77 83
7. K.M. Chu, E.C. Lai, S. Al-Hadeedi, C.E. Arcilla Jr., C.M. Lo, and C.L. Liu Intrahepatic cholangiocarcinoma World J Surg 21 1997 301 306 (Pubitemid 27100493)
8. M. Ohtsuka, H. Ito, F. Kimura, H. Shimizu, A. Togawa, and H. Yoshidome Extended hepatic resection and outcomes in intrahepatic cholangiocarcinoma J Hepatobiliary Pancreat Surg 10 2003 259 264 (Pubitemid 37407515)
9. M. Yamamoto, K. Takasaki, and T. Yoshikawa Extended resection for intrahepatic cholangiocarcinoma in Japan J Hepatobiliary Pancreat Surg 6 1999 117 121
10. M. Shimada, Y. Yamashita, S. Aishima, K. Shirabe, K. Takenaka, and K. Sugimachi Value of lymph node dissection during resection of intrahepatic cholangiocarcinoma Br J Cancer 88 2001 1463 1466 (Pubitemid 32989464)
11. M.A. Glozak, and E. Seto Histone deacetylases and cancer Oncogene 26 2007 5420 5432 (Pubitemid 47255924)
12. W. Weichert HDAC expression and clinical prognosis in human malignancies Cancer Lett 280 2009 168 176
13. D.S. Schrump Cytotoxicity mediated by histone deacetylase inhibitors in cancer cells: mechanisms and potential clinical implications Clin Cancer Res 15 2009 3947 3957
14. R. Bos, P. van der Groep, A.E. Greijer, A. Shvarts, S. Meijer, and H.M. Pinedo Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma Cancer 97 2003 1573 1581 (Pubitemid 36297788)
15. G.W. Huang, L.Y. Yang, and W.Q. Lu Expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in hepatocellular carcinomas: Impact on neovascularization and survival World J Gastroenterol 11 2005 1705 1708
16. E.A. Griffiths, S.A. Pritchard, H.R. Valentine, N. Whitchelo, P.W. Bishop, and M.P. Ebert Hypoxia-inducible factor-1α expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas Br J Cancer 96 2007 95 103 (Pubitemid 46094645)
17. S. Enatsu, A. Iwasaki, T. Shirakusa, M. Hamasaki, K. Nabeshima, and H. Iwasaki Expression of hypoxia-inducible factor-1 alpha and its prognostic significance in small-sized adenocarcinomas on the lung Eur J Cardiothorac Surg 29 2006 891 895 (Pubitemid 43728579)
18. Y. Sumiyoshi, Y. Kakeji, A. Egashira, K. Mizokami, H. Orita, and Y. Maehara Overexpression of hypoxia-inducible factor 1alpha and p53 is a marker for an unfavorable prognosis in gastric cancer Clin Cancer Res 12 2006 5112 5117 (Pubitemid 44453338)
19. M.S. Kim, H.J. Kwon, Y.M. Lee, J.H. Baek, J.E. Jang, and S.W. Lee Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes Nat Med 7 2001 437 443 (Pubitemid 32298546)
20. Y.G. Yoo, G. Kong, and M.O. Lee Metastasis-associated protein 1 enhances stability of hypoxia-inducible factor-1alpha protein by recruiting histone deacetylase 1 EMBO J 25 2006 1231 1241
21. S.H. Kim, K.W. Kim, and J.W. Jeong Inhibition of hypoxia-induced angiogenesis by sodium butyrate, a histone deacetylase inhibitor, through hypoxia-inducible factor-1alpha suppression Oncol Rep 17 2007 793 797
22. S.H. Kim, J.W. Jeong, and J.A. Park Regulation of the HIF-1alpha stability by histone deacetylases Oncol Rep 17 2007 647 651
23. Liver Cancer Study Group of Japan Classification of Primary Liver Cancer 1st English ed 1997 Kanehara Tokyo
24. J.M. Craig, E. Earle, P. Canham, L.H. Wong, M. Anderson, and K.H. Choo Analysis of mammalian proteins involved in chromatin modification reveals new metaphase centromeric proteins and distinct chromosomal distribution patterns Hum Mol Genet 12 2003 3109 3121 (Pubitemid 37508882)
25. A. Mirza, M. McGuirk, T.N. Hockenberry, Q. Wu, H. Ashar, and S. Black Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway Oncogene 21 2002 2613 2622 (Pubitemid 34478319)
26. W. Weichert, A. Röske, V. Gekeler, T. Beckers, M.P. Ebert, and M. Pross Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis Lancet Oncol 9 2008 139 148
27. H. Sasaki, S. Moriyama, Y. Nakashima, Y. Kobayashi, M. Kiriyama, and I. Fukai Histone deacetylase 1 mRNA expression in lung cancer Lung Cancer 46 2004 171 178 (Pubitemid 39330411)
28. Y. Toh, and G.L. Nicolson The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications Clin Exp Metastasis 26 2009 215 227
29. T. Rikimaru, A. Taketomi, Y. Yamashita, K. Shirabe, T. Hamatsu, and M. Shimada Clinical significance of histone deacetylase 1 expression in patients with hepatocellular carcinoma Oncology 72 2007 69 74 (Pubitemid 350249132)
30. K. Miyake, T. Yoshizumi, S. Imura, K. Sugimoto, E. Batmunkh, and H. Kanemura Expression of hypoxia-inducible factor-1alpha, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma correlation with poor prognosis with possible regulation Pancreas 36 2008 e1 e9
31. M. Shimada, K. Sugimoto, S. Iwahashi, T. Utsunomiya, Y. Morine, and S. Imura CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma J Gastroenterol 45 2010 896 902
32. U. Mahlknecht, and C. Schönbein Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells Haematologica 93 2008 443 446 (Pubitemid 351398647)
33. B. Zhang, A.C. Strauss, S. Chu, M. Li, Y. Ho, and K.D. Shiang Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate Cancer Cell 17 2010 427 442